(91 days)
Not Found
No
The document does not mention AI, ML, or related terms, and the device description focuses on standard ultrasound imaging modes and analysis packages.
No
The device is described as a "Diagnostic Ultrasound System" intended for "diagnostic ultrasound imaging and fluid analysis." Its function is to "acquire ultrasound data and to display the data" and allow for "measurement of anatomical structures and analysis packages that provide information that is used to make a diagnosis." There is no mention of treating or alleviating any medical condition.
Yes
The "Intended Use / Indications for Use" section explicitly states, "The HS50 / HS60 Diagnostic Ultrasound System and transducers are intended for diagnostic ultrasound maging and fluid analysis of the human body." Also, the "Device Description" mentions that it offers "analysis packages that provide information that is used to make a diagnosis by competent health care professionals."
No
The device description explicitly states it is a "diagnostic ultrasound system," which inherently includes hardware components (transducers, processing unit, display, etc.) to acquire and display ultrasound data. While it is "software controlled," it is not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states "diagnostic ultrasound imaging and fluid analysis of the human body." This describes an imaging modality used on the body, not a test performed on samples taken from the body.
- Device Description: The description details an ultrasound system that acquires and displays ultrasound data in various modes. This is consistent with an imaging device, not a device that analyzes biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any processes typically associated with in vitro diagnostics.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic purposes. This ultrasound system operates by transmitting and receiving sound waves to create images of internal structures.
N/A
Intended Use / Indications for Use
The HS50 / HS60 Diagnostic Ultrasound System and transducers are intended for diagnostic ultrasound maging and fluid analysis of the human body.
The clinical applications include: Fetal/Obstetrics, Abdominal, Gynecology, Pediatric, Small Organ, Neonatal Cephalic, Adult Cephalic, Trans-rectal, Muscular-Skeletal (Conventional, Superficial), Urology, Cardiac Adult, Cardiac Pediatric, Trans-esophageal(Cardiac) and peripheral vessel.
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
The HS50 / HS60 are a general purpose, mobile, software controlled, diagnostic ultrasound system. Its function is to acquire ultrasound data and to display the data as B mode, M mode, Color M mode, Anatomical mode, Color Doppler mode, Pulsed Wave (PW) Spectral Doppler mode, Continuous Wave (CW) Doppler mode, Tissue Doppler Imaging (TDI) mode, Tissue Doppler Wave (TDW) mode, Power Doppler (PD) mode, ElastoScan Mode, 3D/4D/XI STIC imaging mode, Dual mode, Combined mode, Simultaneous mode and Zoom mode. The HS50 / HS60 also gives the operator the ability to measure anatomical structures and offers analysis packages that provide information that is used to make a diagnosis by competent health care professionals. The HS50 / HS60 have real time acoustic output display with two basic indices, a mechanical index and a thermal index, which are both automatically displayed.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic
Anatomical Site
Human body (Fetal/Obstetrics, Abdominal, Gynecology, Pediatric, Small Organ, Neonatal Cephalic, Adult Cephalic, Trans-rectal, Muscular-Skeletal (Conventional, Superficial), Urology, Cardiac Adult, Cardiac Pediatric, Trans-esophageal(Cardiac) and peripheral vessel.)
Indicated Patient Age Range
Adult, Pediatric, Neonatal (implied by clinical applications such as Neonatal Cephalic, Adult Cephalic, Cardiac Adult, Cardiac Pediatric, Small Organ for adult, pediatric, and neonatal patients).
Intended User / Care Setting
Competent health care professionals (implied by the description of measuring anatomical structures and offering analysis packages for diagnosis).
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The proposed device HS50 / HS60 Ultrasound System, did not require clinical studies to demonstrate substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
December 12, 2019.
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA text logo on the right. The FDA text logo is in blue and includes the acronym "FDA" followed by "U.S. FOOD & DRUG ADMINISTRATION" in a stacked format.
SAMSUNG MEDISON CO., LTD % Scully Kim Regulatory Affairs Specialist 3366, Hanseo-ro, Nam-myeon Hongcheon-gun, Gaungwon-do 25108 REPUBLIC OF KOREA
Re: K192505
Trade/Device Name: HS50/HS60 Diagnostics Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: Class II Product Code: IYN IYO ITX Dated: November 22, 2019 Received: November 25, 2019
Dear Scully Kim:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
1
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name
HS50 / HS60 Diagnostic Ultrasound System
Indications for Use (Describe)
The HS50 / HS60 Diagnostic Ultrasound System and transducers are intended for diagnostic ultrasound maging and fluid analysis of the human body.
The clinical applications include: Fetal/Obstetrics, Abdominal, Gynecology, Pediatric, Small Organ, Neonatal Cephalic, Adult Cephalic, Trans-rectal, Muscular-Skeletal (Conventional, Superficial), Urology, Cardiac Adult, Cardiac Pediatric, Trans-esophageal(Cardiac) and peripheral vessel.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) No.:
Device Name: HS50/HS60 Diagnostic Ultrasound System Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track I only) | Specific | ||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | ||||||||
(Spec.) | Other | ||||||||
(Spec.) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Note 2,3,4, 7, 8, 9, 11 | |||
Abdominal (See Note 10) | P | P | P | P | Note 15 | Note 1 | Note 2,6, 7, 8, 9, 11, 12, 16 | ||
Intra-operative (See Note 6) | |||||||||
Intra-operative (Neuro.) | |||||||||
Fetal Imaging | |||||||||
& Other | Laparoscopic | ||||||||
Pediatric | P | P | P | P | Note 15 | Note 1 | Note 2, 6, 7, 8, 9, 11 | ||
Small Organ (See Note 5) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11, 12 | |||
Neonatal Cephalic | P | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 11 | ||
Adult Cephalic | P | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 11 | ||
Trans-rectal | P | P | P | Note 15 | Note 1 | Notes 2, 7, 8, 9, 11, 12 | |||
Trans-vaginal | P | P | P | Note 15 | Note 1 | Notes 2, 7, 8, 9, 11, 12 | |||
Trans-urethral | |||||||||
Trans-esoph. (non-Cardiac) | |||||||||
Musculo-skel. (Convent.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11, 12 | |||
Musculo-skel. (Superfic.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | |||
Intra-luminal | |||||||||
Other (See Note 13) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 8, 9, 11, 12 | |||
Cardiac | Cardiac Adult | P | P | P | P | Note 15 | Note 1 | Note 4, 7, 14, 17 | |
Cardiac Pediatric | P | P | P | P | Note 15 | Note 1 | Note 4, 7, 14, 17 | ||
Trans-esophageal (Cardiac) | P | P | P | P | Note 15 | Note 1 | Note 4, 7, 14, 17 | ||
Other (spec.) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | P | P | P | P | Note 15 | Note 1 | Note 2, 6, 7, 9, 11 | |
Other (spec.) |
N= new indication; P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+C+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad,
- B+C+CW, B+PD+CW, B+E
- Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
-
Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients -
Note 6: Abdominal organs and peripheral vessel
-
Note 7: Tissue Harmonic Imaging (THI)
-
Note 8: 3D imaging
-
Note 9: MultiVision (Spatial Compound Imaging)
-
Note 10: Includes Renal, Gynecology/Pelvis
-
Note 11: Panoramic imaging
-
Note 12: ElastoScan
-
Note 13: Includes Urology/Prostate
-
Note 14: Tissue Doppler Imaging (TDI)
-
Note 15: Color Doppler includes Power (Amplitude) Doppler
-
Note 16: Contrast Note 17: Strain+
4
510(k) No.:
Device Name: LA3-14AD for use with HS60/ HS50
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track I only) | Specific | ||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | ||||||||
(Spec.) | Other | ||||||||
(Spec.) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal Imaging | |||||||||
& Other | Fetal/Obstetrics (See Note 3) | ||||||||
Abdominal (See Note 10) | |||||||||
Intra-operative (See Note 6) | |||||||||
Intra-operative (Neuro.) | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (See Note 5) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11, 12 | |||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Cardiac) | |||||||||
Musculo-skel. (Convent.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11, 12 | |||
Musculo-skel. (Superfic.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | |||
Intra-luminal | |||||||||
Other (See Note 13) | |||||||||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Trans-esophageal (Cardiac) | |||||||||
Other (spec.) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | P | P | P | Note 15 | Note 1 | Note 2, 6, 7, 9, 11 | ||
Other (spec.) |
N= new indication; P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Note 1: B+M, B+CW, B+C, B+C, B+PD, B+Elastoscan, B+C+PW, B+DD+PW, B+DPD+PW, B+TD+PW, B+C+M, B+C+CW, Dual/Quad (B, B+C, B+PD, B+TD, B+DPD)
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
Note 12: ElastoScan
Note 13: Includes Urology/Prostate Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
Note 16: Contrast
Note 17: Strain+
5
510(k) No.:
Device Name: CA1-7AD for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 11 | ||
Abdominal (See Note 10) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 11, 16 | ||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 11 | ||
Musculo-skel. (Superfic.) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 11 | ||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication; P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+C+PW, B+PD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
Note 16: Contrast
Note 17: Strain+
6
510(k) No.:
Device Name: CF4-9 for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General (Track I only) | Specific (Tracks I & III) | B | M | PWD | CWD | Color Doppler* | Combined* (Spec.) | Other (Spec.) |
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Notes 9, 11 | ||
Abdominal (See Note 10) | P | P | P | Note 15 | Note 1 | Notes 9, 11 | ||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging & Other | Laparoscopic | |||||||
Pediatric | P | P | P | Note 15 | Note 1 | Notes 6, 9, 11 | ||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | P | P | P | P | Note 1 | Notes 9, 11 | ||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral Vessel | Peripheral vessel | P | P | P | Note 15 | Note 1 | Notes 9, 11 | |
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
7
510(k) No.:
Device Name: ER4-9 for use with HS50
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9 | |
Abdominal (See Note 10) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 12 | ||
Trans-vaginal | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 12 | ||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (spec.) (See Note 13) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 12 | ||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication; P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Note 1: B+M, B+CW, B+C, B+C, B+PD, B+Elastoscan, B+C+PW, B+DD+PW, B+DPD+PW, B+TD+PW, B+C+M, B+C+CW, Dual/Quad (B, B+C, B+PD, B+TD, B+DPD)
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
Note 11: Panoramic imaging
Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
Note 16: Contrast
Note 17: Strain+
8
510(k) No.:
Device Name: LA3-16A for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track I only) | Specific | ||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | ||||||||
(Spec.) | Other | ||||||||
(Spec.) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal (See Note 3) | |||||||||
Abdominal (See Note 10) | |||||||||
Intra-operative (See Note 6) | |||||||||
Intra-operative (Neuro.) | |||||||||
Fetal Imaging | |||||||||
& Other | Laparoscopic | ||||||||
Pediatric | |||||||||
Small Organ (See Note 5) | P | P | P | Note 15 | Note 1 | Note 2,7,9,11,12 | |||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Cardiac) | |||||||||
Musculo-skel. (Convent.) | P | P | P | Note 15 | Note 1 | Note 2,7,9,11,12 | |||
Musculo-skel. (Superfic.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | |||
Intra-luminal | |||||||||
Other (See Note 13) | |||||||||
Cardiac Adult | |||||||||
Cardiac | Cardiac Pediatric | ||||||||
Trans-esophageal (Cardiac) | |||||||||
Other (spec.) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | P | P | P | Note 15 | Note 1 | Note 2, 6, 7, 9, 11 | ||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
9
510(k) No.:
Device Name: LA3-16AI for use with HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | Specific | B | M | PWD | CWD | Color | ||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
(Track I only) | (Tracks I & III) | |||||||
Ophthalmic | Ophthalmic | |||||||
Fetal ( See Note 3 ) | ||||||||
Abdominal | ||||||||
Intra-operative ( See Note 6 ) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ ( See Note 5 ) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | P | P | P | Note 15 | Note 1 | Note 7, 9, 11 | ||
Musculo-skel. (Superfic.) | P | P | P | Note 15 | Note 1 | Note 7, 9, 11 | ||
Intra-luminal | ||||||||
Other ( See Note 13 ) | ||||||||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | P | P | Note 15 | Note 1 | Note 6, 7, 9, 11 | |
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
-
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler -
Note 16: Contrast Note 17: Strain+
10
510(k) No.:
Device Name: LA2-9A for use with HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | |||||||
Abdominal (See Note 10) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | ||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (See Note 5) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | ||
Musculo-skel. (Superfic.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | ||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | P | P | Note 15 | Note 1 | Note 2, 6, 7, 9, 11 | |
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
11
510(k) No.:
Device Name: PE2-4 for use with HS50
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track I only) | Specific | ||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | ||||||||
(Spec.) | Other | ||||||||
(Spec.) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal/Obstetrics (See Note 3) | |||||||||
Abdominal (See Note 10) | P | P | P | P | Note 15 | Note 1 | Note 7 | ||
Intra-operative (See Note 6) | |||||||||
Intra-operative (Neuro.) | |||||||||
Fetal Imaging & Other | Laparoscopic | ||||||||
Pediatric | |||||||||
Small Organ (See Note 5) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | P | P | P | P | Note 15 | Note 1 | Note 7 | ||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Cardiac) | |||||||||
Musculo-skel. (Convent.) | |||||||||
Musculo-skel. (Superfic.) | |||||||||
Intra-luminal | |||||||||
Other (See Note 13) | |||||||||
Cardiac Adult | P | P | P | P | P | Note 1 | Note 4, 7, 14, 17 | ||
Cardiac | Cardiac Pediatric | P | P | P | P | P | Note 1 | Note 4, 7, 14, 17 | |
Trans-esophageal (Cardiac) | |||||||||
Other (spec.) | |||||||||
Peripheral Vessel | Peripheral vessel | ||||||||
Other (spec.) |
N= new indication; P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
12
510(k) No.:
Device Name: PA3-8B for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | |||||||
Abdominal (See Note 10) | P | P | P | P | Note 15 | Note 1 | Note 7 | |
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | P | P | P | P | Note 15 | Note 1 | Note 6, 7 | |
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | P | P | P | P | Note 15 | Note 1 | Note 7 | |
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | P | P | P | P | P | Note 1 | Note 4, 7, 14,17 |
Cardiac Pediatric | P | P | P | P | P | Note 1 | Note 4, 7, 14, 17 | |
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
-
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler -
Note 16: Contrast Note 17: Strain+
13
510(k) No.:
Device Name: PE2-4 for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | |||||||
Abdominal (See Note 10) | P | P | P | P | Note 15 | Note 1 | Note 7 | |
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | P | P | P | P | Note 15 | Note 1 | Note 7 | |
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | P | P | P | P | P | Note 1 | Note 4, 7, 14,17 |
Cardiac Pediatric | P | P | P | P | P | Note 1 | Note 4, 7, 14, 17 | |
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
14
510(k) No.:
Device Name: CV1-8AD for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 11 | ||
Abdominal (See Note 10) | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 11 | ||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+C+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
15
510(k) No.:
Device Name: V5-9 for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9 | ||
Abdominal (See Note 10) | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 12 | ||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 12 | ||
Trans-vaginal | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 12 | ||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | P | P | P | Note 15 | Note 1 | Note 2, 7, 8, 9, 12 | ||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
-
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler -
Note 16: Contrast Note 17: Strain+
16
510(k) No.:
Device Name: DP2B for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | |||||||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | P | |||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | P | ||||||
Cardiac Pediatric | P | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | ||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
- Note 13: Includes Urology/Prostate
- Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
Note 9: MultiVision (Spatial Compound Imaging)
17
510(k) No.:
Device Name: CW6.0 for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | |||||||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | P | |||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | P | ||||||
Cardiac Pediatric | P | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | ||||||
Other (spec.) |
N= new indication; P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast
Note 17: Strain+
18
510(k) No.:
Device Name: CA2-9AD for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track I only) | Specific | ||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | ||||||||
(Spec.) | Other | ||||||||
(Spec.) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 11 | |||
Abdominal (See Note 12) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 11 | |||
Intra-operative (See Note 6) | |||||||||
Intra-operative (Neuro.) | |||||||||
Fetal Imaging | |||||||||
& Other | Laparoscopic | ||||||||
Pediatric | |||||||||
Small Organ (See Note 5) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Cardiac) | |||||||||
Musculo-skel. (Convent.) | |||||||||
Musculo-skel. (Superfic.) | |||||||||
Intra-luminal | |||||||||
Other (See Note 13) | |||||||||
Cardiac Adult | |||||||||
Cardiac | Cardiac Pediatric | ||||||||
Trans-esophageal (Cardiac) | |||||||||
Other (spec.) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | ||||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
- Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
- Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
- Note 13: Includes Urology/Prostate
- Note 14: Tissue Doppler Imaging (TDI)
- Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
19
510(k) No.:
Device Name: EA2-11B for use with HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | Specific | B | M | PWD | CWD | Color | Combined* | Other | ||
(Track I only) | (Tracks I & III) | Doppler* | (Spec.) | (Spec.) | ||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9 | ||||
Abdominal (See Note 12) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 12 | ||||
Intra-operative (See Note 6) | ||||||||||
Intra-operative (Neuro.) | ||||||||||
Fetal Imaging | Laparoscopic | |||||||||
& | ||||||||||
Other | Pediatric | |||||||||
Small Organ (See Note 5) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Trans-rectal | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 12 | ||||
Trans-vaginal | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 12 | ||||
Trans-urethral | ||||||||||
Trans-esoph. (non-Cardiac) | ||||||||||
Musculo-skel. (Convent.) | ||||||||||
Musculo-skel. (Superfic.) | ||||||||||
Intra-luminal | ||||||||||
Other (See Note 13) | P | P | P | P | Note 1 | Note 2, 7, 9, 12 | ||||
Cardiac Adult | ||||||||||
Cardiac | Cardiac Pediatric | |||||||||
Trans-esophageal (Cardiac) | ||||||||||
Other (spec.) | ||||||||||
Peripheral | Peripheral vessel | |||||||||
Vessel | Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
Concurrence of Center for Devices and Radiological Health (CDRH) Prescription Use (Per 21 CFR 801.109)
20
510(k) No.:
Device Name: LA4-18BD for use with HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | ||||||||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11, 12 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11, 12 | ||
Musculo-skel. (Superfic.) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 11 | ||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | P | P | Note 15 | Note 1 | Note 2, 6, 7, 9, 11 | |
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
- Note 2: Includes imaging for guidance of biopsy
- Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
- Note 6: Abdominal organs and peripheral vessel
- Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
- Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
- Note 13: Includes Urology/Prostate
- Note 14: Tissue Doppler Imaging (TDI)
- Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
Concurrence of Center for Devices and Radiological Health (CDRH) Prescription Use (Per 21 CFR 801.109)
21
510(k) No.:
Device Name: PA1-5A for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | ||||||||
Abdominal (See Note 12) | P | P | P | P | Note 15 | Note 1 | Note 7 | |
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | P | P | P | P | Note 15 | Note 1 | Note 7 | |
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac Adult | P | P | P | P | Note 15 | Note 1 | Note 4, 7, 14, 17 | |
Cardiac | Cardiac Pediatric | P | P | P | P | Note 15 | Note 1 | Note 4, 7, 14, 17 |
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
Concurrence of Center for Devices and Radiological Health (CDRH) Prescription Use (Per 21 CFR 801.109)
22
510(k) No.:
Device Name: CA3-10A for use with HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | Specific | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | |||||||||
(Spec.) | Other | |||||||||
(Spec.) | ||||||||||
(Track I only) | (Tracks I & III) | |||||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal/Obstetrics (See Note 3) | P | P | P | P | P | Note 1 | Notes 2, 3, 4, 7, 9, 11 | |||
Abdominal (See Note 12) | P | P | P | P | P | Note 1 | Notes 2, 6, 7, 9, 11 | |||
Intra-operative (See Note 6) | ||||||||||
Intra-operative (Neuro.) | ||||||||||
Fetal Imaging | ||||||||||
& Other | Laparoscopic | |||||||||
Pediatric | P | P | P | P | P | Note 1 | Notes 2, 7, 9, 11 | |||
Small Organ (See Note 5) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Trans-rectal | ||||||||||
Trans-vaginal | ||||||||||
Trans-urethral | ||||||||||
Trans-esoph. (non-Cardiac) | ||||||||||
Musculo-skel. (Convent.) | P | P | P | P | P | Note 1 | Notes 2, 7, 9, 11 | |||
Musculo-skel. (Superfic.) | P | P | P | P | P | Note 1 | Notes 2, 7, 9, 11 | |||
Intra-luminal | ||||||||||
Other (See Note 13) | ||||||||||
Cardiac Adult | ||||||||||
Cardiac | Cardiac Pediatric | |||||||||
Trans-esophageal (Cardiac) | ||||||||||
Other (spec.) | ||||||||||
Peripheral | ||||||||||
Vessel | Peripheral vessel | P | P | P | P | P | Note 1 | Notes 2, 7, 9, 11 | ||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336, ; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
- Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
- Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
- Note 13: Includes Urology/Prostate
- Note 14: Tissue Doppler Imaging (TDI)
- Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
23
510(k) No.:
Device Name: CA2-6BM for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track I only) | Specific | ||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | ||||||||
(Spec.) | Other | ||||||||
(Spec.) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal/Obstetrics (See Note 3) | |||||||||
Abdominal (See Note 12) | P | P | P | Note 15 | Note 1 | Notes 2, 7, 9, 11 | |||
Intra-operative (See Note 6) | |||||||||
Intra-operative (Neuro.) | |||||||||
Fetal Imaging | |||||||||
& Other | Laparoscopic | ||||||||
Pediatric | |||||||||
Small Organ (See Note 5) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Cardiac) | |||||||||
Musculo-skel. (Convent.) | |||||||||
Musculo-skel. (Superfic.) | |||||||||
Intra-luminal | |||||||||
Other (See Note 13) | |||||||||
Cardiac Adult | |||||||||
Cardiac | Cardiac Pediatric | ||||||||
Trans-esophageal (Cardiac) | |||||||||
Other (spec.) | |||||||||
Peripheral | Peripheral vessel | ||||||||
Vessel | Other (spec.) |
N= new indication; P= previously cleared by FDA K181336 ; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
24
510(k) No.:
Device Name: VR5-9 for use with HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||
(Track I only) | Specific | |||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||||
Doppler* | Combined* | |||||||||
(Spec.) | Other | |||||||||
(Spec.) | ||||||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal/Obstetrics (See Note 3) | P | P | P | P | Note 1 | Note 2, 7, 8, 9 | ||||
Abdominal (See Note 10) | ||||||||||
Intra-operative (See Note 6) | ||||||||||
Intra-operative (Neuro.) | ||||||||||
Fetal Imaging | ||||||||||
& Other | Laparoscopic | |||||||||
Pediatric | ||||||||||
Small Organ (See Note 5) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Trans-rectal | P | P | P | P | Note 1 | Note 2, 7, 8, 9, 12 | ||||
Trans-vaginal | P | P | P | P | Note 1 | Note 2, 7, 8, 9, 12 | ||||
Trans-urethral | ||||||||||
Trans-esoph. (non-Cardiac) | ||||||||||
Musculo-skel. (Convent.) | ||||||||||
Musculo-skel. (Superfic.) | ||||||||||
Intra-luminal | ||||||||||
Other (See Note 13) | P | P | P | P | Note 1 | Notes 2, 7, 8, 9, 12 | ||||
Cardiac Adult | ||||||||||
Cardiac | Cardiac Pediatric | |||||||||
Trans-esophageal (Cardiac) | ||||||||||
Other (spec.) | ||||||||||
Peripheral | ||||||||||
Vessel | Peripheral vessel | |||||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
25
510(k) No.:
Device Name: EVN4-9 for use with HS50
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | P | P | P | Note 15 | Note 1 | Note 2, 7, 9 | ||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 12 | ||
Trans-vaginal | P | P | P | Note 15 | Note 1 | Note 2, 7, 9, 12 | ||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | P | P | P | P | Note 1 | Note 2, 7, 9, 12 | ||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
26
510(k) No.:
Device Name: PA4-12B for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | |||||||
Abdominal (See Note 12) | P | P | P | P | P | Note 1 | Note 2,15 | |
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | P | P | P | P | P | Note 1 | Note 2,15 | |
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | P | P | P | P | P | Note 1 | Note 2,15 | |
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | P | P | P | P | P | Note 1 | Note 4, 7,15 |
Cardiac Pediatric | P | P | P | P | P | Note 1 | Note 4, 7,15 | |
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
27
510(k) No.:
Device Name: DP8B for use with HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging | ||||||||
& Other | Fetal/Obstetrics (See Note 3) | |||||||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac | Cardiac Adult | P | ||||||
Cardiac Pediatric | P | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | ||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
28
510(k) No.:
Device Name: MMPT3-7 for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | Specific | B | M | PWD | CWD | Color | ||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
(Track I only) | (Tracks I & III) | |||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | ||||||||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | ||||||||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | P | P | P | P | P | Note 1 | Note 4, 7,14, 17 | |
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication: P= previously cleared by FDA K181336; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
Note 9: MultiVision (Spatial Compound Imaging)
Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
Note 13: Includes Urology/Prostate
Note 14: Tissue Doppler Imaging (TDI)
Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
Concurrence of Center for Devices and Radiological Health (CDRH) Prescription Use (Per 21 CFR 801.109)
29
510(k) No.:
Device Name: EA2-11AR for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track I only) | Specific | ||||||||
(Tracks I & III) | B | M | PWD | CWD | Color | ||||
Doppler* | Combined* | ||||||||
(Spec.) | Other | ||||||||
(Spec.) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal/Obstetrics (See Note 3) | N | N | N | Note 15 | Note 1 | Note 2, 7, 9 | |||
Abdominal (See Note 12) | |||||||||
Intra-operative (See Note 6) | |||||||||
Intra-operative (Neuro.) | |||||||||
Fetal Imaging | Laparoscopic | ||||||||
& | |||||||||
Other | Pediatric | ||||||||
Small Organ (See Note 5) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | N | N | N | Note 15 | Note 1 | Note 2, 7, 9, 12 | |||
Trans-vaginal | N | N | N | Note 15 | Note 1 | Note 2, 7, 9, 12 | |||
Trans-urethral | |||||||||
Trans-esoph. (non-Cardiac) | |||||||||
Musculo-skel. (Convent.) | |||||||||
Musculo-skel. (Superfic.) | |||||||||
Intra-luminal | |||||||||
Other (See Note 13) | N | N | N | N | Note 1 | Note 2, 7, 9, 12 | |||
Cardiac Adult | |||||||||
Cardiac | Cardiac Pediatric | ||||||||
Trans-esophageal (Cardiac) | |||||||||
Other (spec.) | |||||||||
Peripheral | Peripheral vessel | ||||||||
Vessel | Other (spec.) |
N= new indication; P= previously cleared by FDA ; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
-
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development -
Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
- Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
- Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
- Note 13: Includes Urology/Prostate
- Note 14: Tissue Doppler Imaging (TDI)
- Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
30
510(k) No.:
Device Name: EA2-11AV for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | N | N | N | Note 15 | Note 1 | Note 2, 7, 9 | ||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | N | N | N | Note 15 | Note 1 | Note 2, 7, 9, 12 | ||
Trans-vaginal | N | N | N | Note 15 | Note 1 | Note 2, 7, 9, 12 | ||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | N | N | N | N | Note 1 | Note 2, 7, 9, 12 | ||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication; P= previously cleared by FDA ; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
- Note 2: Includes imaging for guidance of biopsy
- Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
- Note 6: Abdominal organs and peripheral vessel
- Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
- Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
- Note 13: Includes Urology/Prostate
- Note 14: Tissue Doppler Imaging (TDI)
- Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
Concurrence of Center for Devices and Radiological Health (CDRH) Prescription Use (Per 21 CFR 801.109)
31
510(k) No.:
Device Name: EV2-10A for use with HS50/HS60
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation (*includes simultaneous B-mode) | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I only) | Specific | |||||||
(Tracks I & III) | B | M | PWD | CWD | Color | |||
Doppler* | Combined* | |||||||
(Spec.) | Other | |||||||
(Spec.) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal/Obstetrics (See Note 3) | N | N | N | Note 15 | Note 1 | Note 2, 7,8, 9 | ||
Abdominal (See Note 12) | ||||||||
Intra-operative (See Note 6) | ||||||||
Intra-operative (Neuro.) | ||||||||
Fetal Imaging | ||||||||
& Other | Laparoscopic | |||||||
Pediatric | ||||||||
Small Organ (See Note 5) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | N | N | N | Note 15 | Note 1 | Note 2, 7, 8, 9, 12 | ||
Trans-vaginal | N | N | N | Note 15 | Note 1 | Note 2, 7,8, 9, 12 | ||
Trans-urethral | ||||||||
Trans-esoph. (non-Cardiac) | ||||||||
Musculo-skel. (Convent.) | ||||||||
Musculo-skel. (Superfic.) | ||||||||
Intra-luminal | ||||||||
Other (See Note 13) | N | N | N | N | Note 1 | Note 2, 7, 8, 9, 12 | ||
Cardiac Adult | ||||||||
Cardiac | Cardiac Pediatric | |||||||
Trans-esophageal (Cardiac) | ||||||||
Other (spec.) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (spec.) |
N= new indication; P= previously cleared by FDA ; E= added under Appendix E
Additional Comments:
Color Doppler includes Power (Amplitude) Doppler
Note 1: B+M, B+PW, B+C, B+PD, B+DPD, B+CW, B+C+PW, B+PD+PW, B+DPD+PW, B+TD+PW, B+C+M, Dual/Quad, B+C+CW, B+PD+CW, B+E
Note 2: Includes imaging for guidance of biopsy
Note 3: Includes infertility monitoring of follicle development
- Note 4: Color M-mode
Note 5: For example: thyroid, parathyroid, breast, scrotum and penis in adult, pediatric and neonatal patients
Note 6: Abdominal organs and peripheral vessel
Note 7: Tissue Harmonic Imaging (THI)
- Note 8: 3D imaging
- Note 9: MultiVision (Spatial Compound Imaging)
- Note 10: Includes Renal, Gynecology/Pelvis
- Note 11: Panoramic imaging
- Note 12: ElastoScan
- Note 13: Includes Urology/Prostate
- Note 14: Tissue Doppler Imaging (TDI)
- Note 15: Color Doppler includes Power (Amplitude) Doppler
- Note 16: Contrast Note 17: Strain+
32
K192505
510(K) Summary:
In accordance with 21 CFR 807.92 the following summary of information is provided:
- Date Prepared September 11, 2019 1.
-
- Manufacturer SAMSUNG MEDISON CO., LTD. 3366, Hanseo-ro, Nam-myeon, Hongcheon-gun, Gangwon-do, Republic of Korea
-
- Primary Contact Person Scully Kim Regulatory Affairs Specialist Phone: +82.2.2194.1312 Fax: +82. 31.8017.9576 Email: scully.kim(@samsungmedison.com
-
- Secondary Contact Person Jiyea Lee Regulatory Affairs Specialist Phone: +82.2.2194.1594 Fax: +82. 31.8017.9576 Email: jiyea722.lee(@samsungmedison.com
- న. Proposed Device
- Proprietary Name: HS50/HS60 Diagnostic Ultrasound System -
- Common Name: -System, Imaging, Pulsed Doppler, Ultrasonic System, Imaging, Pulsed Echo, Ultrasonic Transducer, Ultrasonic, Diagnostic
- -Classification: Class II
- Product Code(s): IYN 21 CFR 892.1550 Ultrasonic Pulsed Doppler Imaging System -IYO - 21 CFR 892.1560 Ultrasonic Pulsed Echo Imaging System ITX - 21 CFR 892.1570 Diagnostic Ultrasonic Transducer
-
- Predicate Devices
-
- Device Description
The HS50 / HS60 are a general purpose, mobile, software controlled, diagnostic ultrasound system. Its function is to acquire ultrasound data and to display the data as B mode, M mode, Color M mode, Anatomical mode, Color Doppler mode, Pulsed Wave (PW) Spectral Doppler mode, Continuous Wave (CW) Doppler mode, Tissue Doppler Imaging (TDI) mode, Tissue Doppler Wave (TDW) mode, Power Doppler (PD) mode, ElastoScan Mode, 3D/4D/XI STIC imaging mode, Dual mode, Combined mode, Simultaneous mode and Zoom mode. The HS50 / HS60 also gives the operator the ability to measure
33
anatomical structures and offers analysis packages that provide information that is used to make a diagnosis by competent health care professionals. The HS50 / HS60 have real time acoustic output display with two basic indices, a mechanical index and a thermal index, which are both automatically displayed.
-
- Intended Use
The HS50 / HS60 Diagnostic Ultrasound System and transducers are intended for diagnostic ultrasound imaging and fluid analysis of the human body.
- Intended Use
The clinical applications include: Fetal/Obstetrics, Abdominal, Gynecology, Pediatric, Small Organ, Neonatal Cephalic, Adult Cephalic, Trans-vaginal, Muscular-Skeletal (Conventional, Superficial), Urology, Cardiac Adult, Cardiac Pediatric, Transesophageal(Cardiac) and peripheral vessel.
- Technological Comparison to Predicate Devices 9. The HS50 / HS60 employ the same fundamental scientific technology as its predicate device HS50/ HS60 (K181336).
-
- Determination of Substantial Equivalence
Comparison to Predicate: The HS50/ HS60 are substantially equivalent to the predicate devices with regard to intended use, imaging capabilities, technological characteristics and safety and effectiveness.
- . The systems are all intended for diagnostic ultrasound imaging and fluid flow analysis.
- . The proposed HS50/ HS60 and predicate HS50/ HS60 (K181336) have the same clinical intended use.
- . The proposed HS50/ HS60 and predicate HS50/ HS60 (K181336) have the same imaging modes and modes of operation.
- The proposed HS50/ HS60 add new SW features 2D Follicle and LaborAssist. It . provides similar functionality to 5D Follicle and Sono L&D in predicates HS50/60(K181336) and VOLUSON E series (K181985).
- The transducers EA2-11AR, EA2-11AV and EV2-10A are newly added in this . submission.
- . The proposed HS50/ HS60 add nine new Biopsy KITs.
- The proposed HS50/ HS60 implement Window 10 Operating System. .
- The proposed HS50/ HS60 and predicate HS50/ HS60 (K181336) have same . capability in terms of performing measurements, capturing digital images, reviewing and reporting studies.
- The proposed HS50/ HS60 and predicate HS50/ HS60 (K181336) have been . designed in compliance with approved electrical and physical safety standards.
34
- . The system is manufactured with materials which have been evaluated and found to be safe for the intended use of the device.
- The system has acoustic power levels which are below the applicable FDA limits. .
-
- Summary of Non-Clinical Testing
The device has been evaluated for acoustic output, biocompatibility, software function, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic and mechanical safety, and has been found to conform with applicable FDA guidance and medical device safety standards. The HS50/ HS60 and its applications comply with the following FDA-recognized standards.
Reference No. | Title |
---|---|
IEC 60601-1 | AAMI ANSI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 |
and A2:2010/(R)2012 (Consolidated Text) Medical electrical equipment - | |
Part 1: General requirements for basic safety and essential performance | |
(IEC 60601-1:2005, MOD) | |
IEC 60601-1-2 | IEC60601-1-2: 2014(4th Edition), Medical electrical equipment - Part 1- |
2: General requirements for basic safety and essential performance - EMC | |
IEC 60601-2-37 | IEC 60601-2-37 Edition 2.0 2007, Medical electrical equipment - Part 2- |
37: Particular requirements for the basic safety and essential performance | |
of ultrasonic medical diagnostic and monitoring equipment | |
ISO10993-1 | AAMI / ANSI / ISO 10993-1:2009/(R)2013, Biological evaluation of |
medical devices – Part 1: Evaluation and testing within a risk management | |
process | |
ISO14971 | ISO 14971:2007, Medical devices - Application of risk management to |
medical devices | |
NEMA UD 2-2004 | NEMA UD 2-2004 (R2009) Acoustic Output Measurement Standard for |
Diagnostic Ultrasound Equipment Revision 3 |
12. Summary of Clinical Tests
The proposed device HS50 / HS60 Ultrasound System, did not require clinical studies to demonstrate substantial equivalence.
13. Conclusion
Since the predicate devices and subject device have a similar intended use and key technological features, the non-clinical data support the safety of the device and demonstrate that the HS50 / HS60 Ultrasound System should perform as intended in the specified use conditions. Therefore, SAMSUNG MEDISON CO., LTD. concludes that the performance of the subject device is as safe and effective, and is therefore substantially equivalent, to the predicate device(s) that are currently marketed for the same intended use.